# Trevena (stock symbol: TRVN) Logo in transparent PNG and SVG formats

## Trevena Logo large

### Trevena Logo large Download PNG (39.38 KB)

![Trevena Logo large Download PNG (39.38 KB)](/img/orig/TRVN_BIG-a3b933b5.png)

### Trevena Logo large Download SVG (5.6 KB)

![Trevena Logo large Download SVG (5.6 KB)](/img/orig/TRVN_BIG-8b0a4b23.svg)

## Trevena Logo icon format

### Trevena Logo icon format Download PNG (75.97 KB)

![Trevena Logo icon format Download PNG (75.97 KB)](/img/orig/TRVN-5baa4d04.png)

### Trevena Logo icon format Download SVG (1.36 KB)

![Trevena Logo icon format Download SVG (1.36 KB)](/img/orig/TRVN-4d2a89e8.svg)

## Trevena Logo large for dark backgrounds

### Trevena Logo large for dark backgrounds Download PNG (24.23 KB)

![Trevena Logo large for dark backgrounds Download PNG (24.23 KB)](/img/orig/TRVN_BIG.D-a7d00c5c.png)

### Trevena Logo large for dark backgrounds Download SVG (5.63 KB)

![Trevena Logo large for dark backgrounds Download SVG (5.63 KB)](/img/orig/TRVN_BIG.D-ac67b502.svg)

## Trevena Logo icon format for dark backgrounds

### Trevena Logo icon format for dark backgrounds Download PNG (42.92 KB)

![Trevena Logo icon format for dark backgrounds Download PNG (42.92 KB)](/img/orig/TRVN.D-72fa2548.png)

### Trevena Logo icon format for dark backgrounds Download SVG (1.3 KB)

![Trevena Logo icon format for dark backgrounds Download SVG (1.3 KB)](/img/orig/TRVN.D-ed4f1275.svg)

## About Trevena

Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV027 for the treatment of acute lung injury contributing to acute respiratory distress syndrome and abnormal blood clotting in patients with COVID-19; TRV250, a G protein biased delta-opioid receptor agonist for the treatment of acute migraine; TRV734, a small molecule G protein biased ligand of the MOR for the treatment of moderate-to-severe acute and chronic pain; and TRV045, a novel S1P modulator for managing chronic pain. The company has a collaboration with Imperial College London to evaluate Trv027 in Covid-19 patients. Trevena, Inc. was incorporated in 2007 and is headquartered in Chesterbrook, Pennsylvania.

1. Website domain: trevena.com
2. Employees: 43
3. Marketcap: $5.81 Million USD


## Categories
- [x] ðŸ‡ºðŸ‡¸ United States
- [x] ðŸ’Š Pharmaceuticals
- [x] ðŸ§¬ Biotech
